[HTML][HTML] Evodiamine attenuates experimental colitis injury via activating autophagy and inhibiting NLRP3 inflammasome assembly

W Ding, Z Ding, Y Wang, Y Zhu, Q Gao… - Frontiers in …, 2020 - frontiersin.org
Autophagy and NLRP3 inflammasome were associated with the process of colitis. Drugs
targeting NLRP3 inflammasome and autophagy to treat colitis are absent, and they are …

Evodiamine Attenuates Experimental Colitis Injury Via Activating Autophagy and Inhibiting NLRP3 Inflammasome Assembly.

W Ding, Z Ding, Y Wang, Y Zhu, Q Gao… - Frontiers in …, 2020 - europepmc.org
Autophagy and NLRP3 inflammasome were associated with the process of colitis. Drugs
targeting NLRP3 inflammasome and autophagy to treat colitis are absent, and they are …

Evodiamine attenuates experimental colitis injury via activating autophagy and inhibiting NLRP3 inflammasome assembly.

W Ding, Z Ding, Y Wang, Y Zhu, Q Gao, W Cao, R Du - 2020 - cabidigitallibrary.org
Autophagy and NLRP3 inflammasome were associated with the process of colitis. Drugs
targeting NLRP3 inflammasome and autophagy to treat colitis are absent, and they are …

[HTML][HTML] Evodiamine Attenuates Experimental Colitis Injury Via Activating Autophagy and Inhibiting NLRP3 Inflammasome Assembly

W Ding, Z Ding, Y Wang, Y Zhu, Q Gao… - Frontiers in …, 2020 - ncbi.nlm.nih.gov
Autophagy and NLRP3 inflammasome were associated with the process of colitis. Drugs
targeting NLRP3 inflammasome and autophagy to treat colitis are absent, and they are …

Evodiamine Attenuates Experimental Colitis Injury Via Activating Autophagy and Inhibiting NLRP3 Inflammasome Assembly

W Ding, Z Ding, Y Wang, Y Zhu… - Frontiers in …, 2020 - pubmed.ncbi.nlm.nih.gov
Autophagy and NLRP3 inflammasome were associated with the process of colitis. Drugs
targeting NLRP3 inflammasome and autophagy to treat colitis are absent, and they are …